Trial intelligence / Profile preview

Vitamin D and Bone Metabolism in Children With Epidermolysis Bullosa

NCT05141838Phase 4Unknown

Start
Nov 2020
Primary completion
Jan 2023
Modality
Orthosteric Ligands, Metabolically Activated Prodrugs
Countries
1
01

Overview

Phase 4, open-label trial of vitamin d in Vitamin D deficiency (VDD), osteoporosis and osteopenia (4 arms). Primary endpoints: Vitamin D level at 24 weeks, Phosphorus-calcium metabolism assessment at 24 weeks and 2 more. Status: unknown.

02

Drugs

vitamin d
03

Conditions

Vitamin D deficiency (VDD)osteoporosisosteopenia

Beyond the preview

Go deeper on NCT05141838.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05141838.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call